This product contains 3 different medications: efavirenz, emtricitabine, and tenofovir. It is used alone or with other HIV medications to help control HIV infection. It helps to decrease the ...

(Nasdaq: GILD) announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of ...

FDA Approves Tapentadol for Chronic Pain Tapentadol extended release, already approved for acute pain, has now been given the go ahead for chronic pain. News, August 26, 2011 FDA Approves New Drug ...

In the ECHO and THRIVE trials, 10% of the patients who received rilpivirine-based regimens experienced treatment failure. Nearly half of these patients developed resistance to multiple ...

I’ve spent the last several years covering cannabis and hemp news, business, and culture, with thousands of print and digital articles published in the genre. You’ll find my byline under some ...

Did you know Amazon has a hidden section devoted to secret sales on its own devices? It's true! On any given day, the retail giant adds and removes sales from this secret hub on a handful of Echo ...

Emily Field, an analyst from Barclays, maintained the Hold rating on Gilead Sciences (GILD – Research Report). The associated price ...

Analyst Salveen Richter of Goldman Sachs maintained a Hold rating on Gilead Sciences (GILD – Research Report), with a price target of ...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of ...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of ...